View Single Post
  #2  
Old Thu Jun 21, 2012, 02:18 PM
Neil Cuadra Neil Cuadra is offline
Owner
 
Join Date: Jul 2006
Location: Los Angeles, California
Posts: 2,553
Hi Samantha.

Rigosertib is called not only by its trade name Estybon but also by the name ON 01910, so be sure to search under multiple names when looking for information about it.

In the forums we first talked about rigosertib here when it was a new drug undergoing initial testing, and here last year. A few forum users have mentioned the rigosertib clinical trials, including user "sae36" in a post here.

There are several rigosertib trials currently open, including a Phase II dosage study and a Phase III comparison with other treatments for higher-risk patients. Do you know which trial her doctor is talking about? Has he or she explained the pros and cons of being in a clinical trial and whether there's an alternative treatment if you choose not to participate in the trial?
Reply With Quote